3Ps of Cancer

The Rogel Cancer Center's Associate Chief Clinical Officer of Cancer Services, David Smith, M.D., shares how clinical care delivery for cancer patients at Michigan Medicine had to pivot during the COVID-19 pandemic. See acast.com/privacy for privacy and opt-out information.

Lung cancer is the leading cause of cancer death in the U.S., with an average five-year survival rate of around 20%. Like with most cancers, we know that we can achieve better outcomes for patients when lung cancer is detected at earlier stages. Dr. Doug Arenberg, who heads the lung cancer screening program at the U-M Rogel Cancer Center, discusses lung cancer screening, who benefits, how it's done, along with lung cancer prevention options like smoking cessation that could help in improving survival rate. See acast.com/privacy for privacy and opt-out information.

Dr. Goutham Narla, division chief of genetic medicine in the department of medicine at University of Michigan discusses how his lab pivoted in order to continue much needed cancer research during the COVID-19 pandemic. See acast.com/privacy for privacy and opt-out information.

Dr. Emily Walling, co-medical director and Dr. Anao Zhang, research director for clinical services and patient outcomes of the Michigan Medicine Adolescent and Young Adult Oncology Program discuss this importance and need for this program. See acast.com/privacy for privacy and opt-out information.

When it comes to breast and ovarian cancer risk, there is talk about BRCA1 and BRCA2 gene mutations. In this episode we talk with genetic counselor, Kara Milliron, about BRCA and how it effects not only breast and ovarian cancer but other inherited cancers. See acast.com/privacy for privacy and opt-out information.

Michigan Medicine pathologist, Dr. Aaron Udager talks about pathology’s role in cancer diagnosis. See acast.com/privacy for privacy and opt-out information.

Advanced and metastatic cancer are portrayed as an immediate death sentence, but are they? Radiation oncologist, Daniel Wahl talks about what these terms mean and potential outcomes if diagnosed at a later stage. See acast.com/privacy for privacy and opt-out information.

Dr. Sarah Hawley, co-director of the Rogel Cancer Center’s Center for Health Communications Research and research investigator at the Ann Arbor Veteran’s Affairs hospital discusses intervention and decision making tools for cancer patients. She shares how these online and telephone tools can be used not only for cancer prevention but in ways that can help during your treatment. See acast.com/privacy for privacy and opt-out information.

The Rogel Cancer Cancer is lucky to have two music therapists an staff for patients to receive this intervention that can help promote relaxation, manage pain, improve quality of life among other benefits. Bob Huffman, has been a music therapist at Michigan Medicine for over 15 years. He explains what music therapy is and how it benefits not only patients, but caregivers and staff. The program is a free and is part of the Patient and Family Support Services Program. See acast.com/privacy for privacy and opt-out information.

So many times the media, family and friends talk about battling cancer. We hear it more often when someone has passed away in the terms of "losing their battle with cancer." Dr. Michelle Riba, director of the PsychOncololgy program at the Rogel Cancer Center and associate director of the University of Michigan Comprehensive Depression Center, shares why we should not use militaristic language in talking about cancer.   See acast.com/privacy for privacy and opt-out information.